Date Name Title Filing Type Shares Traded Price Total Held
Jan 03, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 200 -- 3,500
Jan 03, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 957 -- 3,700
Apr 09, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 1,820 -- 3,921
Dec 19, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Other acquisition or disposition -- -- 4,002
Dec 18, 2008
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Other acquisition or disposition -- -- 4,330
Jun 21, 2021
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Open market or private sale of non-derivative or derivative security 10,514 $542.43 4,384
Dec 27, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 800 -- 4,401
Dec 17, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,562 -- 4,562
Jan 03, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 3,800 -- 4,657
Dec 07, 2009
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4 Other acquisition or disposition -- -- 4,694

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.